Publication | Closed Access

Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial

Viral HepatitisImmunologyPegylated Interferon Alfa-2bHepatitisVirologyBoceprevir Versus PlaceboAntiviral Drug DevelopmentAntiviral TherapyAntiviral DrugHivPhase 2Medicine